Evidence map›Paper›PMID 37914954›Full record

ArticleAnalytical and bioanalytical chemistry2023

Simultaneous determination of ergothioneine, selenoneine, and their methylated metabolites in human blood using ID-LC-MS/MS.

Adel Achouba, Pierre Dumas, Pierre Ayotte

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Adel Achouba *Axe santé des populations et pratiques optimales en santé, Centre de recherche du CHU de Québec-Université Laval, 1050 Chemin Sainte-Foy, Québec, QC, G1S 4L8, Canada.
Pierre Dumas *Centre de toxicologie du Québec, Institut national de santé publique du Québec (INSPQ), 945 Wolfe, Québec, QC, G1V 5B3, Canada.
Pierre AyotteAxe santé des populations et pratiques optimales en santé, Centre de recherche du CHU de Québec-Université Laval, 1050 Chemin Sainte-Foy, Québec, QC, G1S 4L8, Canada. pierre.ayotte@inspq.qc.ca.ORCID http://orcid.org/0000-0003-1970-7252
Institut National de Santé Publique du Québec · CAUniversité Laval · CA

Funding

Northern Contaminants Program, Government of Canada H-04
6 · The paper itself

Abstract

Ergothioneine and selenoneine are structurally related dietary antioxidants and cytoprotectants that may help prevent several chronic diseases associated with inflammation and aging. Both compounds share pharmacokinetic characteristics such as cellular uptake through the ergothioneine transporter, accumulation in red blood cells, and biotransformation to methylated metabolites. A rapid, sensitive, specific, precise, and cost-effective analytical method is required to further investigate the potential health benefits of these compounds, individually or combined, in large epidemiological studies. We developed and validated an isotope-dilution liquid chromatography tandem mass spectrometry (ID-LC-MS/MS) method for the simultaneous specific quantification of these analytes in human blood following a simple sample preparation consisting of dilution in aqueous dithiothreitol followed by centrifugal filtration. Chromatographic separation of the analytes is achieved using a reversed-phase chromatography within an 8-min run. Analyte detection is performed using triple quadrupole mass spectrometry in multiple reaction monitoring mode. Each analyte is quantified against its corresponding isotopically labeled internal standard either commercially available or synthesized in-house (

Indexed as

ErgothioneineChromatography, High Pressure LiquidChromatography, LiquidHistidineHumansIsotopesOrganoselenium CompoundsReproducibility of ResultsTandem Mass SpectrometryErgothioneineHistidineIsotopesOrganoselenium CompoundsselenoneineErgothioneineHuman bloodIsotope-dilution LC–MS/MSSelenoneine

Identifiers

PMID37914954
OpenAlexW4388230774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.